Method of assembling and filling a drug delivery device

US2016199583A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016199583-A1
Application numberUS-201615047815-A
CountryUS
Kind codeA1
Filing dateFeb 19, 2016
Priority dateOct 14, 2011
Publication dateJul 14, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product, including a granulocyte colony-stimulating factor (G-CSF). The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

First claim

Opening claim text (preview).

We claim: 1 . A method of assembling an injector, the method comprising: providing a container having a wall defining an interior surface and a seal assembly having an interior surface, the wall and seal assembly defining a reservoir; providing a fluid delivery system physically separate from the container, the fluid delivery system comprising a container needle having a point; sterilizing the container including the reservoir and fluid delivery system while the container and the fluid delivery system are separate from each other; filling the sterile reservoir of the container with a volume of a drug product under sterile conditions, the drug product comprising a granulocyte colony-stimulating factor (G-CSF); attaching the fluid delivery system to the filled container under clean room conditions such that the point of the container needle is disposed adjacent to the seal assembly to define a storage state; attaching the container needle to an actuator, the actuator adapted to move the container needle from the storage state to a delivery state wherein the container needle is disposed through the seal assembly, into the sterile reservoir, and in fluid communication with the drug product for delivery to a patient. 2 . The method of claim 1 , further comprising packaging the injector. 3 . The method of claim 1 , further comprising attaching a stopper to the container after filling the reservoir, thereby sealing the filler reservoir. 4 . The method of claim 1 , wherein attaching the fluid delivery system to the filled container comprises attaching the container needle such that the container needle does not penetrate a wall of the seal assembly. 5 . The method of claim 1 , wherein sterilizing the container comprises (a) using e-beam technology, (b) treatment with chlorine dioxide, (c) treatment with vapor phase hydrogen peroxide, and/or (d) treatment with a currently-known sterilization method. 6 . The method of claim 1 , wherein filling the sterile reservoir of the container includes filling the sterile reservoir in a space operated as an aseptic Class 100 clean room. 7 . The method of claim 4 , wherein attaching the stopper to the container includes attaching the stopper to the container in a space operated as an aseptic Class 100 clean room. 8 . The method of claim 1 , prior to attaching the fluid delivery system to the container, inspecting the filled container in a space operated as an aseptic Class 10,000 clean room. 9 . The method of claim 1 , prior to attaching the fluid delivery system to the container, moving the filled container to an assembly space operated as an aseptic Class 10,000 clean room. 10 . The method of claim 1 , further comprising swabbing a surface of the seal assembly prior to attaching the fluid delivery system.

Assignees

Inventors

Classifications

  • Filling medical containers such as ampoules, vials, syringes or the like · CPC title

  • with fixed or steady piercing means, e.g. piercing under movement of ampoule · CPC title

  • by liquids or gases · CPC title

  • Methods of manufacture, assembly or production · CPC title

  • adapted to be carried by the patient, e.g. portable on the body · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016199583A1 cover?
An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product, including a granulocyte colony-stimulating factor (G-CSF). The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid conta…
Who is the assignee on this patent?
Amgen Inc
What technology area does this patent fall under?
Primary CPC classification A61M5/2466. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jul 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).